OKUR
OnKure Therapeutics, Inc.
2.90$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | +178.9% | -89.6% | +123.4% | +221.6% | -45.9% | |
| – | +179.4% | -91.1% | +147.9% | +234.7% | -46.2% | |
| – | +132.5% | -90.7% | +158.8% | +270.7% | -46.7% | |
| – | +175.4% | -92.2% | +158.8% | +270.7% | -46.7% | |
| – | -93.0% | +933.6% | +95.4% | -91.9% | -46.4% | |
| – | +35.4% | -10.6% | +31.5% | +44.5% | -43.8% | |
| – | – | – | +37.7% | +157.7% | +2.4% | |
| – | – | – | +35.6% | -13.1% | -51.7% | |
| – | – | -137.0% | – | – | -45.9% | |
| – | – | – | – | – | – | |
| – | -27.9% | +635.2% | +0.0% | +0.0% | +1.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.